Trade Hoth Therapeutics - HOTH CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0201 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.8393 |
| Open | 0.8231 |
| 1-Year Change | -28.04% |
| Day's Range | 0.8231 - 0.8577 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 0.8393 | 0.0303 | 3.75% | 0.8090 | 0.8573 | 0.8090 |
| Apr 23, 2025 | 0.8238 | 0.0466 | 6.00% | 0.7772 | 0.8369 | 0.7772 |
| Apr 22, 2025 | 0.7812 | 0.0330 | 4.41% | 0.7482 | 0.8038 | 0.7472 |
| Apr 21, 2025 | 0.7582 | 0.0110 | 1.47% | 0.7472 | 0.7672 | 0.7199 |
| Apr 17, 2025 | 0.7761 | -0.0111 | -1.41% | 0.7872 | 0.8179 | 0.7595 |
| Apr 16, 2025 | 0.7746 | 0.0283 | 3.79% | 0.7463 | 0.7918 | 0.7456 |
| Apr 15, 2025 | 0.7884 | -0.0388 | -4.69% | 0.8272 | 0.8652 | 0.7772 |
| Apr 14, 2025 | 0.8272 | 0.0268 | 3.35% | 0.8004 | 0.8292 | 0.7975 |
| Apr 11, 2025 | 0.7996 | 0.0124 | 1.58% | 0.7872 | 0.8203 | 0.7483 |
| Apr 10, 2025 | 0.7972 | -0.0100 | -1.24% | 0.8072 | 0.8072 | 0.7397 |
| Apr 9, 2025 | 0.8010 | 0.1237 | 18.26% | 0.6773 | 0.8212 | 0.6664 |
| Apr 8, 2025 | 0.6895 | -0.0777 | -10.13% | 0.7672 | 0.7972 | 0.6478 |
| Apr 7, 2025 | 0.7780 | -0.0192 | -2.41% | 0.7972 | 0.8042 | 0.7572 |
| Apr 4, 2025 | 0.8272 | -0.0500 | -5.70% | 0.8772 | 0.8873 | 0.8112 |
| Apr 3, 2025 | 0.9222 | -0.0050 | -0.54% | 0.9272 | 0.9527 | 0.9072 |
| Apr 2, 2025 | 0.9644 | -0.0207 | -2.10% | 0.9851 | 1.0372 | 0.9084 |
| Apr 1, 2025 | 0.9719 | -0.0053 | -0.54% | 0.9772 | 0.9916 | 0.9377 |
| Mar 31, 2025 | 0.9882 | -0.0290 | -2.85% | 1.0172 | 1.0172 | 0.9674 |
| Mar 28, 2025 | 1.0172 | 0.0200 | 2.01% | 0.9972 | 1.0272 | 0.9972 |
| Mar 27, 2025 | 0.9972 | -0.0100 | -0.99% | 1.0072 | 1.0172 | 0.9972 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Hoth Therapeutics Company profile
About Hoth Therapeutics Inc
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a therapy for dermatological disorders including atopic dermatitis (eczema), chronic wounds, psoriasis, asthma and acne. The Company is also focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer, a treatment for asthma and allergies using inhalational administration, a topical treatment for patients with lupus, a treatment for mast-cell derived cancers and anaphylaxis, and a treatment for lung diseases resulting from bacterial infections. The Company's product pipelines include HT-001, HT-003, HT-004 and others. HT-001 is used to treat patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor (EGFR) inhibitor therapy. It is also developing a COVID-19 treatment as well as a diagnostic device for the detection of viruses via a mobile device.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Hoth Therapeutics Inc revenues was not reported. Net loss increased 68% to $10.8M. Higher net loss reflects Research and development increase from $2.1M to $5.4M (expense), Compensation and related expenses (inclu increase from $1.2M to $2.5M (expense), Other general and administrative expense increase of 68% to $606K (expense).
| Industry: | Pharmaceuticals (NEC) |
1 Rockefeller Plz Ste 1039
10020-2003
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com